Efgartigimod alfa – March 2026

  • Brand names:
    • Vyvgart®
  • Pharmaceutical Company:
    • ARGENX AUSTRALIA PTY. LTD.
  • Condition/Indication: Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Meeting Date: March 2026
Public Summary Documents
Last updated
13 November 2026